EMJ GOLD

In an era when UX is becoming fundamental to businesses globally, the role of design teams in pharma companies is taking on a whole new meaning.

Many of the most transformative innovations are taking place in the developing world on an increasingly regular basis. This article explores this phenomenon in healthcare and the key lessons pharma can take when creating their own innovative products.

Pharma is seeing a host of ground-breaking innovations, with companies developing new technologies that are changing patients’ lives and helping to develop a more patient-centric industry

As podcasts become a popular medium for learning and knowledge sharing, should the pharmaceutical industry give them a go as a way to educate patients and healthcare professionals?

How can the pharmaceutical industry lead the way in data transparency and give more patients the confidence to share their records with researchers?

It has become clear that healthcare professionals don’t want to be sold to. They want to be partners with industry and be treated as such. How can the rep model evolve to stay in line with expectations?

The increasing focus on patient centricity in recent years has ensured pharmaceutical companies are far more in sync with the issues that patients’ face on a day-to-day basis than ever before; however, translating these insights into treatment improvements remains a challenge.

Decline in R&D productivity levels is rapidly becoming one of the biggest challenges for the pharmaceutical industry, but what can it do?

Victoria Elegant, Vice President and Region Head of Medical, Amgen, shares insights on the importance of diversity in delivering innovation, pharma in the JAPAC region and what medical affairs teams across the globe can learn from China.

Perfectly positioned to bridge the gap between R&D and commercial, MA must seize their strategic position within the industry to guide the future of the function.

The regulatory ecosystem of the pharmaceutical industry and people’s decreasing attention spans is proving a complex reality for marketers that has provided an imperative to innovate.

What helps people to stick to their medication regimes, and how can pharma begin to recover their revenue as well as striving for better health outcomes?

A roundtable discussion with two millennial doctors to find out what they want from pharma, both in terms of digital content, rep interactions and more.

Gitte Aabo, President and CEO, LEO Pharma A/S, speaks about LEO’s leading position in dermatology and life-changing moments which help foster the patient-centric environment and mindset that is embedded so deeply within the company.

How can medical affairs teams construct a game plan to make sure they are prepared for the changing landscape within big data?

Amid the digital and data revolution, the rise of social media, and increasing consumer expectations, pharma marketers must up their game to beat competitors.